Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)
CNY 3.25
(0.31%)
CNY 3.25
(0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 82.46 Million | 523.07 Million | 442.95 Million | 364.53 Million | 2.09 Billion | -169.41 Million |
| Net Income | 31.97 Million | -1.73 Billion | 382.01 Million | 624.55 Million | -434.97 Million | 1.27 Billion |
| Depreciation & Amortization | 219.68 Million | 283.88 Million | 319.21 Million | 289.34 Million | 274.82 Million | 234.34 Million |
| Deferred income taxes | -170.86 Million | -101.57 Million | -177.44 Million | -59.92 Million | 38.13 Million | 142.42 Million |
| Stock-based compensation | 19.29 Million | - | - | - | - | - |
| Change in working capital | -432.74 Million | 136.71 Million | -966.66 Million | -1.16 Billion | -14.79 Million | -2.45 Billion |
| Other non-cash items | 329.45 Million | 1.84 Billion | 708.38 Million | 612.06 Million | 2.26 Billion | 768.7 Million |
| Investing Cash Flow | 579.53 Million | 592.95 Million | -583.51 Million | -944.03 Million | -1.31 Billion | -1.57 Billion |
| Investments in PPE | -298.38 Million | -170.96 Million | -461.08 Million | -505.39 Million | -934.87 Million | -604.31 Million |
| Acquisitions | 1.16 Billion | 1.03 Billion | 8.67 Million | -116.24 Million | -146.14 Million | -800.95 Million |
| Investment purchases | -296.82 Million | -273.33 Million | -49.5 Million | -410.08 Million | -199 Million | -84.6 Million |
| Sales/Maturities of investments | 11.14 Million | 32.76 Million | 21.17 Million | 28.85 Million | 11.73 Million | 359.53 Thousand |
| Other Investing Activities | -1.65 Million | -29.14 Million | -102.77 Million | 58.82 Million | -50.34 Million | -89.99 Million |
| Financing Cash Flow | -677.19 Million | -1.46 Billion | -50.41 Million | -1.05 Billion | -267.99 Million | 2.27 Billion |
| Debt repayment | -1.43 Billion | -4.33 Billion | -6.81 Billion | -9.78 Billion | -17.8 Billion | -15.11 Billion |
| Dividends payments | -201.69 Million | -13.26 Million | -26.37 Million | -346.56 Million | -77.81 Million | -516.05 Million |
| Common Stock Repurchased | -28.54 Million | -29.57 Million | -4.4 Million | -8.02 Million | -72.34 Million | - |
| Common Stock Issuance | - | 29.57 Million | 4.4 Million | 8.02 Million | 72.34 Million | - |
| Other Financing Activities | -1.82 Billion | 3.02 Billion | 7.07 Billion | 9.06 Billion | 18.03 Billion | 17.89 Billion |
| Accounts receivables | 1.12 Billion | -6.33 Billion | -197.2 Million | -198.13 Million | -979.79 Million | -5.34 Billion |
| Accounts payables | -1.21 Billion | 6.38 Billion | -1.06 Billion | -1.25 Billion | 401.7 Million | 3 Billion |
| Inventory | -165.26 Million | 190.71 Million | 476.9 Million | 377.98 Million | 525.15 Million | -276.01 Million |
| Other working capital | -1.38 Billion | -101.57 Million | -177.44 Million | -87.69 Million | 38.13 Million | -2.17 Billion |
| Cash at beginning of period | 487.14 Million | 836.23 Million | 1.02 Billion | 2.64 Billion | 2.13 Billion | 1.61 Billion |
| Cash at end of period | 471.94 Million | 487.14 Million | 836.23 Million | 1 Billion | 2.64 Billion | 2.13 Billion |
| Capital Expenditure | -298.38 Million | -170.96 Million | -461.08 Million | -505.39 Million | -934.87 Million | -604.31 Million |
| Effect of forex changes on cash | -924.40 | 4016.01 | -1504.51 | 1566.03 | -0.05 | 152.88 Thousand |
| Net cash flow / Change in cash | -15.2 Million | -349.08 Million | -190.97 Million | -1.63 Billion | 507.9 Million | 521.58 Million |
| Free Cash Flow | -215.91 Million | 352.11 Million | -18.13 Million | -140.85 Million | 1.15 Billion | -773.73 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.78 Million | 15.85 Million | 15.16 Million | 1.09 Million | 31.97 Million | -11.44 Million |
| Depreciation & Amortization | - | 55.67 Million | 55.67 Million | 219.68 Million | 219.68 Million | -86.36 Million |
| Deferred income taxes | - | - | - | - | -170.86 Million | 394.7 Million |
| Stock-based compensation | - | - | - | 19.29 Million | 19.29 Million | -11.91 Million |
| Change in working capital | - | -173.12 Million | - | 956.62 Million | -432.74 Million | -296.42 Million |
| Other non-cash items | -5.67 Million | 105.65 Million | -69.25 Million | -1.42 Billion | 329.45 Million | 165.32 Million |
| Investing Cash Flow | 9.67 Million | 179.94 Million | 74.28 Million | 139.75 Million | 579.53 Million | -136.35 Million |
| Investments in PPE | -26.23 Million | -10.38 Million | -12.74 Million | -256.86 Million | -298.38 Million | -8.5 Million |
| Acquisitions | 33.57 Million | 55.81 Million | 81.41 Million | 370.99 Million | 1.16 Billion | 92.54 Million |
| Investment purchases | - | -37.53 Million | -16.41 Million | -18.64 Million | -296.82 Million | -270.44 Million |
| Sales/Maturities of investments | 2.33 Million | 172.05 Million | 6.2 Million | 10.33 Million | 11.14 Million | 63.25 Thousand |
| Other Investing Activities | - | 192.74 Million | 87.03 Million | 69.96 Million | -1.65 Million | 50 Million |
| Financing Cash Flow | -171.64 Million | -75.82 Million | 110.6 Million | 150.67 Million | -677.19 Million | -481.02 Million |
| Debt repayment | -88.57 Million | -157.97 Million | -575.81 Million | -1.94 Billion | -1.43 Billion | -546.75 Million |
| Dividends payments | - | -40.42 Million | -67.54 Million | -89.12 Million | -201.69 Million | -95.28 Million |
| Common Stock Repurchased | - | - | - | -28.54 Million | -28.54 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -260.22 Million | -648.79 Million | 753.96 Million | -1.79 Billion | -1.82 Billion | 161.01 Million |
| Accounts receivables | - | -365.72 Million | - | 1.12 Billion | 1.12 Billion | -225.27 Million |
| Accounts payables | - | - | - | - | -1.21 Billion | - |
| Inventory | - | 192.59 Million | - | -165.26 Million | -165.26 Million | -71.14 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.94 Billion | 4.02 Billion | 471.94 Million | 431.54 Million | 487.14 Million | 895.11 Million |
| Cash at end of period | 4.68 Billion | 3.94 Billion | 602.74 Million | 471.94 Million | 471.94 Million | 431.54 Million |
| Capital Expenditure | -26.23 Million | -10.38 Million | -12.74 Million | -256.86 Million | -298.38 Million | -8.5 Million |
| Effect of forex changes on cash | - | - | - | -924.00 | -924.40 | -63.25 Thousand |
| Net cash flow / Change in cash | 746.56 Million | -81.45 Million | 130.8 Million | 40.39 Million | -15.2 Million | -463.56 Million |
| Free Cash Flow | -24.12 Million | 55.45 Million | -66.83 Million | -506.89 Million | -215.91 Million | 145.36 Million |
EESH
HQH
FCUV
HPR
2284
3IINFOLTD